Using DISSPLA at NIH

Using DISSPLA at NIH
Author :
Publisher :
Total Pages : 88
Release :
ISBN-10 : UOM:39015029998518
ISBN-13 :
Rating : 4/5 ( Downloads)

Book Synopsis Using DISSPLA at NIH by : National Institutes of Health (U.S.). Division of Computer Research and Technology. Computer Center

Download or read book Using DISSPLA at NIH written by National Institutes of Health (U.S.). Division of Computer Research and Technology. Computer Center and published by . This book was released on 1988 with total page 88 pages. Available in PDF, EPUB and Kindle. Book excerpt:


Using DISSPLA at NIH Related Books

Using DISSPLA at NIH
Language: en
Pages: 88
Authors: National Institutes of Health (U.S.). Division of Computer Research and Technology. Computer Center
Categories: Computer programs
Type: BOOK - Published: 1988 - Publisher:

DOWNLOAD EBOOK

Using DISSPLA at NIH
Language: en
Pages: 0
Authors:
Categories: Computer software
Type: BOOK - Published: 1988 - Publisher:

DOWNLOAD EBOOK

The Prevention and Treatment of Missing Data in Clinical Trials
Language: en
Pages: 163
Authors: National Research Council
Categories: Medical
Type: BOOK - Published: 2010-12-21 - Publisher: National Academies Press

DOWNLOAD EBOOK

Randomized clinical trials are the primary tool for evaluating new medical interventions. Randomization provides for a fair comparison between treatment and con
Sharing Clinical Trial Data
Language: en
Pages: 236
Authors: Institute of Medicine
Categories: Medical
Type: BOOK - Published: 2015-04-20 - Publisher: National Academies Press

DOWNLOAD EBOOK

Data sharing can accelerate new discoveries by avoiding duplicative trials, stimulating new ideas for research, and enabling the maximal scientific knowledge an
The Role of NIH in Drug Development Innovation and Its Impact on Patient Access
Language: en
Pages: 103
Authors: National Academies of Sciences, Engineering, and Medicine
Categories: Medical
Type: BOOK - Published: 2020-01-27 - Publisher: National Academies Press

DOWNLOAD EBOOK

To explore the role of the National Institutes of Health (NIH) in innovative drug development and its impact on patient access, the Board on Health Care Service